Polypore International — Investor Presentation (March 2009)
27 slides from Polypore International's investor presentation, Mar 30, 2009
Slide 1: Investor Presentation April 2009
(NYSE Listed: PPO) Investor Presentation April 2009
Slide 2: Forward-looking statements
These materials include "forward-looking statements". All statements other than statements of historical facts included in these materials that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, i
Slide 3: Polypore Overview
Polypore Overview ROBERT TOTH President & Chief Executive Officer
Slide 4: Leading global high technology filtration company specializing in microporous membranes
Polypore is a leading global high technology filtration company specializing in microporous membranes
Slide 5: Polypore is well positioned for long-term growth
Polypore is well positioned for long-term growth Leading market positions Our markets have an attractive mix of growth and stability characteristics Proven innovation through a breadth of proprietary process and product technology Global infrastructure and customer base Polypore is well positioned t
Slide 6: Leading positions in our business segments
Leading positions in our business segments Lead acid battery separators for... Auto/truck Forklifts Backup power Polypore separator Lithium battery separators for... Portable hand-held devices Power tools Hybrid electric vehicles Hemodialysis Blood oxygenation Plasmapheresis Liquid filtration Gasifi
Slide 7: Differentiation in high performance filtration increasingly depends on membrane technology
Differentiation in high performance filtration increasingly depends on membrane technology Polypore products Flat sheet Hollow fiber Tubular Modules Phase separation Dry stretch Multi-layer Multiple polymers Water & beverage filtration Semiconductor and flat panel display manufacturing Lithium batte
Slide 8: High growth market with significant upside potential
High growth market with significant upside potential Energy Storage - - Electronics Membrane separators for lithium batteries Emerging substantial growth opportunities Low Lithium-ion penetration High
Slide 9: Emergence of Lithium-ion technology in HEV/EVs
Nickel Lithium-ion Stack 3 Stack 4 Stack 5 Stack 6 Stack 7 Stack 8 Totals (invisible) Stack 9 Stack 10 Stack 11 Stack 12 Stack 13 Stack 14 Stack 15 Stack 16 Base Year 2008 17 0 17 50 2009 10 8 18 70 2010 1 9 10 80 2011 and beyond 0 13 13 Available/planned HEV/EV new model launches Representative OEM
Slide 10: Energy Storage - Transportation & Industrial: replacement batteries are 80% of sales
Replacement batteries are 80% of sales 1982 439.1 1987 515.2 1992 613.5 1997 677.8 2002 787.2 2006 900 Number of vehicles in operation worldwide Source: WardsAuto.com (through 2004), 2006 based on Company management estimates 1982-2006 CAGR = 3+% Energy Storage - - Transportation & Industrial High r
Slide 11: Lead-Acid Battery Separator Business Update
Lead-Acid Battery Separator Business Update 2009 performance expected to be below 2008 results Loss of customer contract on 12/31/2008 OEM and Industrial demand weakness Supply chain management challenges FTC hearing scheduled to begin 5/12/2009
Slide 12: Separations Media - Healthcare
Separations Media - - Healthcare Membranes for medical applications Blood Oxygenation >6% market growth Clinically demonstrated best-in-class PUREMA(r) membrane Completed transformation from cellulosics to synthetics Significant growth achieved with PUREMA(r) Critical mass with long-term contract wi
Slide 13: Separations Media - Industrial & Specialty Filtration
Separations Media - - Industrial & Specialty Filtration Polypore is well positioned to serve high-growth and high-value membrane filtration opportunities Membranes & modules for industrial & specialty applications OEM membranes Liqui-Flux(r) Modules Technology driven growth opportunities New applica
Slide 14: Polypore serves attractive end markets
Polypore serves attractive end markets * Excluding Microporous Acquisition, revenue growth was 6% ** Excludes Cellulosic Hemodialysis membrane sales which were discontinued in 2007. Sales were comparable to prior year when including Cellulosics.
Slide 15: Global infrastructure and customer base
Global infrastructure and customer base East Europe 0.35 North America 0.26 Other 0.08 Asia 0.3 Slice 7 Slice 8 Slice 9 Slice 10 Slice 11 Slice 12 Slice 13 Slice 14 Slice 15 Slice 16 2008 Net Sales by Geography* Manufacturing facility Sales office Operating headquarters Operations * Net sales by cus
Slide 16: Solid 2008 Business Performance
Solid 2008 Business Performance Aside from challenges in the lead-acid business, solid 2008 financial performance in difficult macroeconomic environment 2008 Adjusted EBITDA growth from $155 million in 2007 to $176 million* in 2008 Net debt/Adjusted EBITDA reduced from 6.8x pre-IPO to 4.1x at 2008 y
Slide 17: Current Macro-Economic Environment
Current Macro-Economic Environment High recurring revenue base of business Lead-acid replacement business (approximately 80% of transportation) less affected by economy Healthcare largely unaffected by economy A majority of our filtration business (food, beverage and pharma) is less sensitive to the
Slide 18: Financials
Financials LYNN AMOS Chief Financial Officer
Slide 19: Growing revenue and Adjusted EBITDA
Growing revenue and Adjusted EBITDA Adjusted EBITDA ($ millions) Net sales ($ millions) * Adjusted EBITDA includes $2.0 million of cellulosic restructuring add-backs not allowed in Adjusted EBITDA per the prior Credit Agreement 2000PF 349 2001 229.9 15.9 2002 88 2003 136 2004 159 2005 134 2006* 142
Slide 20: Best-in-class Adjusted EBITDA and cash flow margins
Best-in-class Adjusted EBITDA and cash flow margins Cash flow margin* (LTM) Source: Management estimates of peer company information based on public filings (with last twelve month information for the most recent period available for each respective company) Defined as Adjusted EBITDA less capex Adj
Slide 21: No Material Debt Maturities Until 2012
No Material Debt Maturities Until 2012 - If any of the 8.75% bonds due on 5/12/2012 are outstanding on 2/1/2012, then the term loans will mature on that date Polypore has an undrawn $90 million revolver
Slide 22: Cash & Liquidity Summary
Cash & Liquidity Summary Strengthened our capital structure over the last 2 years: 2007 IPO proceeds paid off 10.5% senior discount notes Simultaneously refinanced senior debt and revolving credit facilities in covenant-light deal Approximately $170MM in total liquidity between cash on hand and avai
Slide 23: Polypore has a large non-cash amortization expense
Polypore has a large non-cash amortization expense - - 2008 EPS impact of approximately $0.31
Slide 24: Polypore is well positioned for long-term growth
Polypore is well positioned for long-term growth Leading market positions Our markets have an attractive mix of growth and stability characteristics Proven innovation through a breadth of proprietary process and product technology Global infrastructure and customer base Polypore is well positioned t
Slide 25: Appendix
APPENDIX
Slide 26: Non-GAAP Supplemental Information
Non-GAAP Supplemental Information Adjusted EBITDA is a non-GAAP financial measure presented herein as a supplemental disclosure to net income and reported results. Adjusted EBITDA is defined in Polypore's credit agreement and represents earnings before interest, taxes, depreciation and amortization
Slide 27: Appendix A
Appendix A in millions) Add: Depeation and amortization. Interest expense, net Income taxes EBITDA Stock compensation Foreign currency (gain) loss Loss on disposal of property, plant, and equipment Business restructuring Pro forma results for acquisitions Strike-related costs FTC-telated costs Disco
Polypore International — Investor Presentation (March 2009) on 6ix